ABVC BioPharma, Inc. (ABVC) Revenue 2018–2025
ABVC BioPharma, Inc. (ABVC) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$296,000FY2025 · since FY2018: $6,956 → $296,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $296,000 | -41.9% |
| FY2024 | $509,589 | +234.3% |
| FY2023 | $152,430 | -84.3% |
| FY2022 | $969,783 | +172.6% |
| FY2021 | $355,797 | -26.3% |
| FY2020 | $483,045 | -31.2% |
| FY2019 | $701,719 | +9988.0% |
| FY2018 | $6,956 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABVC financial trends
ABVC Net incomeABVC Net marginABVC Gross profitABVC Gross marginABVC Operating incomeABVC Operating marginABVC Operating cash flowABVC Free cash flowABVC Capital expendituresABVC Return on equityABVC Stock buybacksABVC Dividends paidABVC Total assetsABVC Total liabilitiesABVC Shareholders’ equityABVC overview →